Archivo del sitio

Effektivität und Sicherheit von Rituximab beim Pemphigus: Ergebnisse aus dem Deutschen Register für Autoimmunerkrankungen

Klinik für Dermatologie, Allergologie und Venerologie, Universität Lübeck, Deutschland  Klinik für Dermatologie und Allergologie, Philipps-Universität Marburg, Deutschland  Klinik und Poliklinik für Dermatologie und Venerologie, Universität Köln, Deutschland  Klinik für Dermatologie, Technische Universität Dresden, Deutschland  Abteilung Rheumatologie, LMU München, Deutschland  Abteilung

Etiquetado con: , , ,
Publicado en: Todo el mundo, Noticias e información, Tratamiento y medicación

A long–term study of a patient with anti-p200 pemphigoidcorrelation of autoantibody levels with disease activity and an example of epitope spreading

Anti-p200 pemphigoid is a rare subepidermal blistering disease associated with autoantibodies against a 200kDa protein, reportedly corresponding to laminin γ1. However, direct evidence of the pathogenic potential of these antibodies is missing. We have followed up a patient with anti-p200

Etiquetado con: , , ,
Publicado en: Todo el mundo, Investigación clínica

Why Lesions Occur at Different Sites

By Grant J. Anhalt, M.D. Johns Hopkins Dermatology I will attempt to clarify what we know about the antibody response in various forms of pemphigus and how the distribution of the targeted antigens affects the location of lesions. The synthesis

Etiquetado con: , , , , , , , ,
Publicado en: Médicos

Diagnostic Patterns and Delays in PV: Experience With 99 Pacientes

By David A. Sirois, D.M.D., Ph.D.Department of Oral Medicine Pemphigus vulgaris is a chronic autoimmune disease affecting the mucosa and skin and resulting in epithelial acantholysis, bullae formation, and chronic ulceration.1 Skin lesions of pemphigus vulgaris present clinically with typical

Etiquetado con: , , , ,
Publicado en: Médicos
El registro de p y p ha sido aprobado por la Junta de revisión institucional de occidental (WIRB) y activamente es inscribir participantes.